Allworth Financial LP Boosts Holdings in Colgate-Palmolive (NYSE:CL)

Allworth Financial LP boosted its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 16.2% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 17,890 shares of the company’s stock after purchasing an additional 2,500 shares during the quarter. Allworth Financial LP’s holdings in Colgate-Palmolive were worth $1,857,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Diversify Advisory Services LLC purchased a new position in Colgate-Palmolive in the 1st quarter worth approximately $911,000. TD Asset Management Inc lifted its holdings in shares of Colgate-Palmolive by 2.4% during the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock valued at $103,969,000 after purchasing an additional 26,987 shares in the last quarter. Empowered Funds LLC boosted its position in shares of Colgate-Palmolive by 277.3% during the first quarter. Empowered Funds LLC now owns 33,082 shares of the company’s stock valued at $2,979,000 after buying an additional 24,314 shares during the last quarter. M&G Plc bought a new stake in Colgate-Palmolive in the 1st quarter worth about $3,812,000. Finally, Sei Investments Co. raised its position in Colgate-Palmolive by 41.5% in the 1st quarter. Sei Investments Co. now owns 598,639 shares of the company’s stock worth $53,901,000 after buying an additional 175,445 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, EVP Gregory Malcolm sold 10,533 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the sale, the executive vice president now directly owns 10,377 shares of the company’s stock, valued at approximately $1,069,868.70. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, insider Panagiotis Tsourapas sold 14,794 shares of the business’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the sale, the insider now directly owns 5,146 shares in the company, valued at $529,729.24. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Gregory Malcolm sold 10,533 shares of the company’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the sale, the executive vice president now owns 10,377 shares in the company, valued at $1,069,868.70. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,490 shares of company stock worth $4,486,063 in the last 90 days. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Stock Down 4.1 %

CL opened at $95.61 on Monday. The stock has a market cap of $78.44 billion, a price-to-earnings ratio of 30.26, a price-to-earnings-growth ratio of 3.54 and a beta of 0.40. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The firm’s fifty day moving average is $103.15 and its 200 day moving average is $98.06. Colgate-Palmolive has a fifty-two week low of $71.46 and a fifty-two week high of $109.30.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its earnings results on Friday, October 25th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.88 by $0.03. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The firm had revenue of $5.03 billion during the quarter, compared to analysts’ expectations of $5.01 billion. On average, sell-side analysts forecast that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.09%. Colgate-Palmolive’s dividend payout ratio is currently 63.29%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on CL. Evercore ISI lifted their price target on shares of Colgate-Palmolive from $100.00 to $106.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their target price for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. Hsbc Global Res cut Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a report on Friday, July 26th. Barclays upped their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Finally, Redburn Atlantic raised Colgate-Palmolive to a “hold” rating in a research report on Thursday, August 1st. One analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and a consensus target price of $106.00.

Get Our Latest Analysis on CL

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.